Skip to main content
49°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Annovis Bio Inc
(NY:
ANVS
)
9.090
-0.190 (-2.05%)
Official Closing Price
Updated: 7:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Annovis Bio Inc
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Peering Into Annovis Bio's Recent Short Interest
May 29, 2024
Via
Benzinga
Annovis Announces New Publication in a Peer-Reviewed Journal
May 21, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
May 17, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
May 16, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors
May 16, 2024
From
Law Offices of Frank R. Cruz
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 14, 2024
Via
Benzinga
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
May 13, 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results
May 13, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
May 09, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
May 06, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
S&P 500 Edges Higher; ON Semiconductor Earnings Top Views
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?
April 29, 2024
Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite slight improvements in mild cases, results show no significant difference in...
Via
Benzinga
Stocks Quietly Climb Ahead Of Central Bank Storm
April 29, 2024
The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are all sporting comfortable leads this afternoon.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 29, 2024
Via
Benzinga
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease
April 29, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
April 02, 2024
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
April 02, 2024
From
Annovis Bio Inc.
Via
GlobeNewswire
Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 20, 2024
Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
Via
Benzinga
Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday
March 20, 2024
U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
March 06, 2024
It's time to offload stocks in the automotive, aerospace, and biotech sectors due to emerging financial and operational risks.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's After-Market Session
February 16, 2024
Via
Benzinga
3 Growth Stocks to Sell in February Before They Bottom
February 12, 2024
Discover why these growth stocks to sell are facing adversities in automotive retail, aerospace, defense and biotechnology.
Via
InvestorPlace
Dow Edges Lower; US Composite PMI Rises In January
January 24, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 24, 2024
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 24, 2024
Via
Benzinga
Crude Oil Rises Over 1%; DuPont Shares Plunge
January 24, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Wednesday. The Dow traded up 0.36% to 38,040.66 while the NASDAQ rose 0.97% to 15,574.97. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Annovis Bio (ANVS) Stock Is Getting Hammered
January 24, 2024
Annovis Bio shares are trading lower by 20.6% to $9.24 during Wednesday's session. The company announced a delay in the release of Phase III study data for buntanetap in Parkinson's Disease.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.